更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
《Fierce Biotech 2025年裁员追踪:Applied Tx裁员46%;Ensoma亦进行人员削减》
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
罗氏签署2亿美元协议,引进Freenome癌症筛查血液检测技术——Fierce Biotech报道
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech
罗氏口服SERD药物二期临床试验再传捷报,三期辅助乳腺癌试验达标——Fierce Biotech报道
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial Fierce Biotech
罗氏报告BTK抑制剂在多发性硬化症三期试验中取得突破,成功超越竞争对手——Fierce Biotech报道
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed Fierce Biotech
因中国将解除测序仪出口禁令,Illumina股价上涨——Fierce Biotech报道
Illumina shares rise as China set to lift sequencer export ban Fierce Biotech
罗氏签署20亿美元协议,试水Manifold Bio脑部递送技术——Fierce Biotech报道
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain Fierce Biotech
Illumina三季度在华遇阻致销售持平,CEO称与相关机构保持沟通——Fierce Biotech报道
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies Fierce Biotech
Thermo Fisher以90亿美元收购临床试验技术公司Clario,扩充业务版图——Fierce Biotech报道
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal Fierce Biotech
罗氏与中国企业达成价值10亿美元呼吸道疾病双特异性抗体协议——Fierce Biotech报道
Roche pens $1B biobucks deal for Chinese company's respiratory disease bispecific Fierce Biotech
龙沙集团将收购快速微生物检测公司Redberry SAS——激烈生物科技
Lonza to buy rapid microbial testing firm Redberry SAS Fierce Biotech
罗氏在早期阶段清理中砍掉4项中外制药实体瘤资产——Fierce Biotech报道
BIOTECH Roche axes 4 Chugai solid tumor assets in early-phase clear-out By Nick Paul Taylor Oct 23, 2025 4:53am Roche Chugai solid tumor endometriosis Roche has dropped...
中国定价压力持续影响罗氏诊断业务
China pricing pressure continues to weigh on Roche's diagnostics business Fierce Biotech
赛默飞世尔三季度销售额因新品上市与获批激增5%——Fierce Biotech报道
Thermo Fisher sales jump 5% in Q3 amid new launches, approvals Fierce Biotech
罗氏获FDA批准阿尔茨海默症生物标志物血液检测技术——Fierce Biotech报道
Roche nabs FDA clearance for Alzheimer's biomarker blood test Fierce Biotech
Illumina推出AI信息学业务,助力多组学药物研发 - 生物科技前沿
Illumina launches AI informatics business for multi-omic drug discovery Fierce Biotech
罗氏“前三强”减肥药目标不依赖单一重磅炸弹——Fierce Biotech报道
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster Fierce Biotech
Illumina在收购SomaLogic前启动蛋白质制备平台推广 - 激烈生物科技
Illumina begins rolling out protein prep platform ahead of SomaLogic buy Fierce Biotech
10x Genomics收购Scale Biosciences及其单细胞分析试剂盒——Fierce Biotech报道
10x Genomics scoops up Scale Biosciences and its single-cell analysis kits Fierce Biotech
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页